FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2792612660> ?p ?o ?g. }

• W2792612660 endingPage "160" @default.
• W2792612660 startingPage "152" @default.
• W2792612660 abstract "Chitosan oligosaccharides (COS), linear polymers of N-acetyl-D-glucosamine and deacetylated glucosamine, exhibit diverse pharmacological effects such as antimicrobial, antitumor, antioxidant and anti-inflammatory activities. Here, we explored their hypocholesterolemic effects in vivo and the molecular mechanisms of COS in hepatic cells. Our in vivo study of dyslipidemic ApoE-/- male mice showed that COS treatment of 500 mg kg-1 d-1 for 4 weeks clearly reduced the lipid deposits in the aorta and significantly decreased the hepatic proprotein convertase subtilisin/kexin type 9 (PCSK9) protein levels versus HFD groups (p < 0.05). To elucidate the mechanisms behind these effects, the HepG2 cell line was treated with COS. We found that COS (200 μg/ml) increased the amount of cell-surface low-density lipoprotein receptor (LDLR) and enhanced the lipid droplets in HepG2 cells (p < 0.05). The mRNA levels of LDLR and HMG-CoA protein levels were not altered, and the mRNA levels of PCSK9 were down-regulated by COS treatment for 24 h. We also observed that the expression levels of SREBP-2 (125 kD) and HNF-1α were increased in total cell lysates, but nuclear SREBP-2 (nSREBP-2, 68 kD, the active subunit of SREBP-2) levels were decreased and FOXO3a levels increased in nuclear lysates after COS treatment for 24 h. We demonstrated that one of the reasons for regulation of lipid transfer with COS is that FOXO3a levels are up-regulated by COS, leading to a reduction in the PCSK9 promoter binding capacity of HNF-1α and thus suppressing PCSK9 gene expression, up-regulating LDLR levels, and enhancing the lipid droplets in HepG2 cells. In addition, decreased expression of the PCSK9 gene was also contributed to by down-regulation of SREBP-2 by COS. We further confirmed the effect of suppression of PCSK9 expression by COS by utilizing RNA interference to silence HNF-1α and SREBP-2. Finally, to the best of our knowledge, we are the first to demonstrate that PCSK9 expression and LDLR activity are synergistically changed by a combination of HNF-1α and SREBP-2 after COS treatment. Our findings indicate that COS may regulate PCSK9 to modulate hepatic LDLR abundance and activity." @default.
• W2792612660 created "2018-03-29" @default.
• W2792612660 creator A5001277500 @default.
• W2792612660 creator A5021083697 @default.
• W2792612660 creator A5053397364 @default.
• W2792612660 creator A5067850361 @default.
• W2792612660 creator A5069780439 @default.
• W2792612660 date "2018-05-01" @default.
• W2792612660 modified "2023-10-01" @default.
• W2792612660 title "Chitosan oligosaccharides enhance lipid droplets via down-regulation of PCSK9 gene expression in HepG2 cells" @default.
• W2792612660 cites W1970516435 @default.
• W2792612660 cites W1976178988 @default.
• W2792612660 cites W1988805720 @default.
• W2792612660 cites W1989193708 @default.
• W2792612660 cites W2004869456 @default.
• W2792612660 cites W2017894064 @default.
• W2792612660 cites W2023369448 @default.
• W2792612660 cites W2031215262 @default.
• W2792612660 cites W2033486224 @default.
• W2792612660 cites W2036240047 @default.
• W2792612660 cites W2039125408 @default.
• W2792612660 cites W2040373341 @default.
• W2792612660 cites W2047695409 @default.
• W2792612660 cites W2064877960 @default.
• W2792612660 cites W2070126347 @default.
• W2792612660 cites W2072106287 @default.
• W2792612660 cites W2097632838 @default.
• W2792612660 cites W2103025142 @default.
• W2792612660 cites W2109254242 @default.
• W2792612660 cites W2114234533 @default.
• W2792612660 cites W2126616270 @default.
• W2792612660 cites W2130820087 @default.
• W2792612660 cites W2141452792 @default.
• W2792612660 cites W2144549290 @default.
• W2792612660 cites W2158901329 @default.
• W2792612660 cites W2163372122 @default.
• W2792612660 cites W2165463540 @default.
• W2792612660 cites W2168113482 @default.
• W2792612660 cites W2520525934 @default.
• W2792612660 cites W2538437447 @default.
• W2792612660 cites W2551462346 @default.
• W2792612660 cites W2559664119 @default.
• W2792612660 cites W2574585825 @default.
• W2792612660 cites W2576896005 @default.
• W2792612660 cites W2584853938 @default.
• W2792612660 cites W2587148203 @default.
• W2792612660 cites W4292172722 @default.
• W2792612660 doi "https://doi.org/10.1016/j.yexcr.2018.03.013" @default.
• W2792612660 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29548750" @default.
• W2792612660 hasPublicationYear "2018" @default.
• W2792612660 type Work @default.
• W2792612660 sameAs 2792612660 @default.
• W2792612660 citedByCount "19" @default.
• W2792612660 countsByYear W27926126602018 @default.
• W2792612660 countsByYear W27926126602019 @default.
• W2792612660 countsByYear W27926126602020 @default.
• W2792612660 countsByYear W27926126602022 @default.
• W2792612660 countsByYear W27926126602023 @default.
• W2792612660 crossrefType "journal-article" @default.
• W2792612660 hasAuthorship W2792612660A5001277500 @default.
• W2792612660 hasAuthorship W2792612660A5021083697 @default.
• W2792612660 hasAuthorship W2792612660A5053397364 @default.
• W2792612660 hasAuthorship W2792612660A5067850361 @default.
• W2792612660 hasAuthorship W2792612660A5069780439 @default.
• W2792612660 hasConcept C104317684 @default.
• W2792612660 hasConcept C150194340 @default.
• W2792612660 hasConcept C150903083 @default.
• W2792612660 hasConcept C153911025 @default.
• W2792612660 hasConcept C170493617 @default.
• W2792612660 hasConcept C207001950 @default.
• W2792612660 hasConcept C25095133 @default.
• W2792612660 hasConcept C2778125326 @default.
• W2792612660 hasConcept C2778163477 @default.
• W2792612660 hasConcept C2778849439 @default.
• W2792612660 hasConcept C2780072125 @default.
• W2792612660 hasConcept C2780948078 @default.
• W2792612660 hasConcept C43554185 @default.
• W2792612660 hasConcept C55493867 @default.
• W2792612660 hasConcept C62746215 @default.
• W2792612660 hasConcept C85051948 @default.
• W2792612660 hasConcept C86803240 @default.
• W2792612660 hasConceptScore W2792612660C104317684 @default.
• W2792612660 hasConceptScore W2792612660C150194340 @default.
• W2792612660 hasConceptScore W2792612660C150903083 @default.
• W2792612660 hasConceptScore W2792612660C153911025 @default.
• W2792612660 hasConceptScore W2792612660C170493617 @default.
• W2792612660 hasConceptScore W2792612660C207001950 @default.
• W2792612660 hasConceptScore W2792612660C25095133 @default.
• W2792612660 hasConceptScore W2792612660C2778125326 @default.
• W2792612660 hasConceptScore W2792612660C2778163477 @default.
• W2792612660 hasConceptScore W2792612660C2778849439 @default.
• W2792612660 hasConceptScore W2792612660C2780072125 @default.
• W2792612660 hasConceptScore W2792612660C2780948078 @default.
• W2792612660 hasConceptScore W2792612660C43554185 @default.
• W2792612660 hasConceptScore W2792612660C55493867 @default.
• W2792612660 hasConceptScore W2792612660C62746215 @default.
• W2792612660 hasConceptScore W2792612660C85051948 @default.
• W2792612660 hasConceptScore W2792612660C86803240 @default.

• next